Dolby Laboratories (DLB) EBT (2009 - 2026)

Dolby Laboratories' EBT history runs 18 years deep, the most recent figure standing at $119.7 million for Q1 2026.

• Quarterly EBT changed 0.46% year-over-year to $119.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $288.5 million (down 8.76% YoY) and the FY2025 annual result came in at $303.5 million, down 2.88% from the prior year.
• EBT was $119.7 million for Q1 2026 at Dolby Laboratories, up from $71.6 million in the prior quarter.
• Across five years, EBT topped out at $121.7 million in Q1 2024 and bottomed at $9.0 million in Q3 2023.
• A 5-year average of $69.5 million and a median of $59.7 million in 2024 frame the typical range for EBT.
• Annual changes were most pronounced in 2023 — EBT plunged 70.84% — and 2024, when it surged 561.29%.
• Dolby Laboratories' EBT stood at $100.0 million in 2022, then retreated by 19.15% to $80.8 million in 2023, then increased by 6.46% to $86.1 million in 2024, then fell by 16.79% to $71.6 million in 2025, then soared by 67.17% to $119.7 million in 2026.
• Business Quant data shows DLB's EBT at $119.7 million in Q1 2026, $71.6 million in Q4 2025, and $41.7 million in Q3 2025.